Navigation Links
Pharma Base S.A. Launches Osamine(TM) Pharmaceutical Grade Glucosamine in North America
Date:4/24/2008

PFAFFIKON, Switzerland, April 24 /PRNewswire/ -- Pharma Base S.A. announces the launch of Osamine(TM) Pharmaceutical Grade Glucosamine for the North American Dietary Supplement, Personal Care and Food industries. Available as both Glucosamine Hydrochloride and Glucosamine Sulphate, Osamine(TM) brings forward high quality pharmaceutical grade glucosamine to the worldwide marketplace.

"With a greater focus on ingredient quality and a strong demand for raw material sources outside of China, the North American marketplace is ready for a superior quality ingredient like Osamine(TM). Having been sold over the last decade in Europe, Japan and India, we are thrilled to introduce this ingredient to the Americas." says Russ Anderson, President of Pharma Base North America.

About Pharma Base

Pharma Base S.A., founded in 1996, is a privately-held company dedicated to improving the lives of people through the research and discovery of naturally occurring compounds. Our commitment is to manufacture and distribute clinically proven, safe and effective high-quality products manufactured in cGMP facilities, thereby helping to elevate the standards and quality of dietary supplements. The company is headquartered in Switzerland with additional locations in India and North America.
For more information:

http://www.osamine.com

http://www.pharmabase.com


'/>"/>
SOURCE Pharma Base S.A.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related medicine news :

1. Prime Hires Rachelle Wan as Vice President of Pharmaceutical Trade Relations
2. The Quigley Corporation Reports First Quarter 2008 Results - Increases Investment in Pharmaceutical R&D Future
3. Pharmacyclics Reports Third Quarter 2008 Financial Results
4. Complimentary Excerpt Available from Best Practices: Pharmaceutical Competitive Intelligence Excellence - Optimizing Data Collection within Approved Guidelines
5. Jazz Pharmaceuticals to Present at Morgan Stanley Conference
6. Aida Pharmaceuticals, Inc. Announces Availability of Downloadable Corporate Synopsis on its Website
7. Medco, UnitedHealth Group Announce Pharmacy Services Agreement
8. Simcere Pharmaceutical Group Acquires 70% Stake in Wuhu Zhong Ren Pharmaceutical Co. Ltd.
9. ISTA Pharmaceuticals Announces Conference Call and Webcast of First Quarter 2008 Financial Results
10. Law Offices of Howard G. Smith Announces 21 Days Remaining to Move to Be a Lead Plaintiff in the Shareholder Lawsuit Against Vertex Pharmaceuticals Inc.
11. Amylin Pharmaceuticals Reports First Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2008)...ould report side effects, but critics want agency ...6 (HealthDay News) -- Direct-to-consumer drug ads ...ber that would allow consumers to report adverse s... , The experts serve on a panel that advises th...mbers are already mandated by the FDA for print ad...
(Date:5/16/2008)...from an international, multicenter Phase III clini... therapy everolimus (RAD001) significantly delays ...ney cancer whose disease had worsened on other tre...an attending physician at Memorial Sloan-Kettering...ngs on May 31 at the annual meeting of the America...
(Date:5/16/2008)...o Save Vital Services for Frail Seniors and People...wswire-USNewswire/ -- Thousands of,homecare worker...warzenegger,s proposed cuts to hours of service, w...ornia,s most vulnerable workers and the,people the...these vital,services for seniors and people with d...
(Date:5/16/2008)... country needs is more unemployed politicians - an...FirstCall/ -- Although nearly all,voters place hea...s" list,a looming federal budgetary crunch means ...he current presidential candidates is likely to be...ority Leader Bill Frist., Jousting with Princeton...
Breaking Medicine News(10 mins):Health News:FDA Panel Considers Toll-Free Number for TV Drug Ads 2Health News:FDA Panel Considers Toll-Free Number for TV Drug Ads 3Health News:Drug fends off kidney cancer progression 2Health News:Homecare Workers Outraged by Proposed Cuts, Wage Reductions 2Health News:Former Senate Majority Leader, Princeton Economist Joust on Future of Health Care 2Health News:Former Senate Majority Leader, Princeton Economist Joust on Future of Health Care 3
...in American women found that most of them had insu...ntal and physical health// , personal lives, profe...urvey sponsored by the National Sleep Foundation, ...s 18 t0 65 spread all over America and found that ...
Diminishing Differences and Empowering Eves
...nd HIV positive during 2006 and, among them, over ...thers// who were either suffering from full-blown ...as said. Epidemiologist Guennadi Onitshenko said ... born of AIDS carrier parents have not developed s...
... injured at least 35 people who need medical treat...erate// quake measuring 4.8 on Richter scale hit I...of the quake, which occurred at 2 a.m., was atDaro...d an official of the city governor's office. The ...
Other Medicine News:Health News:Sleep Problems of Women 2Health News:Diminishing Differences and Empowering Eves 2Health News:Diminishing Differences and Empowering Eves 3
(Date:5/15/2008)... ROCKVILLE, Md., May 15 /PRNewswire-FirstCall/...hat it has completed enrollment in the Phase I/IIa... a total of approximately,230 subjects. Favorable ...,which included dose-escalation in 70 healthy adul...interim findings suggested that the vaccine,is wel...
(Date:5/15/2008)... Medicare Advantage Fee-For-Service Plan Positions...w Business, According to a New Report from ...LE, Tenn., May 15 /- HealthLeaders-In...ket intelligence, reports that as the,economy cont...eld of,Michigan remains the best equipped of all o...
(Date:5/15/2008)... Randomized TRIAS HR Pilot Study Compares Geno... Taxus(R), Other Presentations Focus on Real-W...ts with AMI, Those Who Could Not Tolerate Dual-Ant... BARCELONA, Spain, May 15 /- OrbusNei...sentations in a symposium at EuroPCR 2008,support ...
(Date:5/15/2008)... GREEN BAY, Wis., May 15 /- Omega...be further considered as a credible natural,altern...y in ADHD patients,recent in vivo French study re...ial effects of omega-3 in hyperactivity, French re...d have specific positive effects on,impulse contro...
Breaking Medicine Technology:Novavax Completes Enrollment in Phase I/IIa Pandemic Influenza Vaccine Clinical Trial 2Novavax Completes Enrollment in Phase I/IIa Pandemic Influenza Vaccine Clinical Trial 3Blue Cross Blue Shield Of Michigan Battles Sluggish Economy With Diverse Product Lineup 2Multiple Clinical Data Presentations at EuroPCR 2008 Support Use of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) as Safe Alternative to Drug-Eluting Stents 2Multiple Clinical Data Presentations at EuroPCR 2008 Support Use of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) as Safe Alternative to Drug-Eluting Stents 3Multiple Clinical Data Presentations at EuroPCR 2008 Support Use of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) as Safe Alternative to Drug-Eluting Stents 4Omega 3 Fatty Acids Bound to Phospholipids has Potential Benefit for Attention-Deficit Hyperactivity Disorder (ADHD) 2Omega 3 Fatty Acids Bound to Phospholipids has Potential Benefit for Attention-Deficit Hyperactivity Disorder (ADHD) 3New Computerized Scans Effective for Spotting Clogged Arteries 5516 1New Computerized Scans Effective for Spotting Clogged Arteries 5516 2New Computerized Scans Effective for Spotting Clogged Arteries 5516 3Baxter Kidney Patient Education Program Celebrates Tenth Anniversary 1687 1Baxter Kidney Patient Education Program Celebrates Tenth Anniversary 1687 2Baxter Kidney Patient Education Program Celebrates Tenth Anniversary 1687 3Baxter Kidney Patient Education Program Celebrates Tenth Anniversary 1687 4Keryx Biopharmaceuticals Inc Announces Positive Preliminary Phase 2 Data on KRX 0401 in Patients with Chemo Insensitive Rare Sarcoma 752 1Keryx Biopharmaceuticals Inc Announces Positive Preliminary Phase 2 Data on KRX 0401 in Patients with Chemo Insensitive Rare Sarcoma 752 2Keryx Biopharmaceuticals Inc Announces Positive Preliminary Phase 2 Data on KRX 0401 in Patients with Chemo Insensitive Rare Sarcoma 752 3Keryx Biopharmaceuticals Inc Announces Positive Preliminary Phase 2 Data on KRX 0401 in Patients with Chemo Insensitive Rare Sarcoma 752 4Keryx Biopharmaceuticals Inc Announces Positive Preliminary Phase 2 Data on KRX 0401 in Patients with Chemo Insensitive Rare Sarcoma 752 5Keryx Biopharmaceuticals Inc Announces Positive Preliminary Phase 2 Data on KRX 0401 in Patients with Chemo Insensitive Rare Sarcoma 752 6Progen Presents Additional Analysis of Data from PI 88 Phase 2 Liver Cancer Study at American Association for the Study of Liver Diseases 749 1Progen Presents Additional Analysis of Data from PI 88 Phase 2 Liver Cancer Study at American Association for the Study of Liver Diseases 749 2Progen Presents Additional Analysis of Data from PI 88 Phase 2 Liver Cancer Study at American Association for the Study of Liver Diseases 749 3
The latest from the leader in automatic slide stainers. It offers a truly unique and modern approach to slide staining, ending messy procedures. The instrument of choice for peripheral blood smears,
Cholesterol single reagent. Storage temp: 2 - 8 C. Linearity: 0 - 600 mg. Expected values: Recommended 240 mg/dL. Available with calibrator and performed 500 number of test.
For the quantitative determination of total cholesterol in serum.
Intended for the quantitative determination of total cholesterol in serum. Reaction: Endpoint. Reaction complete within five minutes. Wavelength: 500 nm. Linearity: 700 mg/dL (18.1 mmol/L). Single st
Medicine Products: